1 December 2024 false Taxfiler 2024.6 3631732business:PrivateLimitedCompanyLtd2024-12-012025-11-30 36317322024-11-30 36317322024-12-012025-11-30 3631732business:AuditExemptWithAccountantsReport2024-12-012025-11-30 3631732business:FilletedAccounts2024-12-012025-11-30 36317322025-11-30 3631732business:Director12024-12-012025-11-30 3631732business:Director22024-12-012025-11-30 3631732business:CompanySecretary12024-12-012025-11-30 3631732business:RegisteredOffice2024-12-012025-11-30 36317322024-11-30 3631732core:WithinOneYear2025-11-30 3631732core:WithinOneYear2024-11-30 3631732core:AfterOneYear2025-11-30 3631732core:AfterOneYear2024-11-30 3631732core:ShareCapitalcore:PreviouslyStatedAmount2025-11-30 3631732core:ShareCapitalcore:PreviouslyStatedAmount2024-11-30 3631732core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-11-30 3631732core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-11-30 3631732core:PreviouslyStatedAmount2025-11-30 3631732core:PreviouslyStatedAmount2024-11-30 3631732business:SmallEntities2024-12-012025-11-30 3631732countries:EnglandWales2024-12-012025-11-30 3631732core:Goodwill2024-11-30 3631732core:Goodwill2024-12-012025-11-30 3631732core:Goodwill2025-11-30 3631732business:OrdinaryShareClass12024-12-012025-11-30 3631732business:OrdinaryShareClass12023-12-012024-11-30 3631732business:OrdinaryShareClass22024-12-012025-11-30 3631732business:OrdinaryShareClass22023-12-012024-11-30 3631732business:AllOrdinaryShares2024-12-012025-11-30 3631732business:AllOrdinaryShares2023-12-012024-11-30 36317322023-12-012024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 3631732 (England and Wales)
ADVANCE PHARMACIES LTD Unaudited accounts for the year ended 30 November 2025
ADVANCE PHARMACIES LTD Unaudited accounts Contents
Page
- 2 -
ADVANCE PHARMACIES LTD Company Information for the year ended 30 November 2025
Directors
Nadeem Iqbal Mazair Iqbal
Secretary
Mazair Iqbal
Company Number
3631732 (England and Wales)
Registered Office
188 Lichfield Road Rushall Walsall West Midlands WS4 1ED England
Accountants
Caldwell House Consulting 44 Caldwell Road Birmingham West Midlands B9 5TQ
- 3 -
ADVANCE PHARMACIES LTD Statement of financial position as at 30 November 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Intangible assets
320,000 
310,000 
Current assets
Inventories
35,508 
- 
Debtors
396,294 
362,571 
Cash at bank and in hand
990,973 
1,330,054 
1,422,775 
1,692,625 
Creditors: amounts falling due within one year
(312,977)
(86,009)
Net current assets
1,109,798 
1,606,616 
Total assets less current liabilities
1,429,798 
1,916,616 
Creditors: amounts falling due after more than one year
(1,340,989)
(1,758,165)
Net assets
88,809 
158,451 
Capital and reserves
Called up share capital
200 
200 
Profit and loss account
88,609 
158,251 
Shareholders' funds
88,809 
158,451 
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 15 May 2026 and were signed on its behalf by
Mazair Iqbal Director Company Registration No. 3631732
- 4 -
ADVANCE PHARMACIES LTD Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
ADVANCE PHARMACIES LTD is a private company, limited by shares, registered in England and Wales, registration number 3631732. The registered office is 188 Lichfield Road, Rushall, Walsall, West Midlands, WS4 1ED, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 December 2024
310,000 
Additions
320,000 
Disposals
(310,000)
At 30 November 2025
320,000 
Amortisation
At 1 December 2024
- 
At 30 November 2025
- 
Net book value
At 30 November 2025
320,000 
At 30 November 2024
310,000 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
62,299 
275,798 
Trade debtors
333,995 
86,773 
396,294 
362,571 
- 5 -
ADVANCE PHARMACIES LTD Notes to the Accounts for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
290,096 
61,173 
Taxes and social security
6,171 
11,234 
Other creditors
16,710 
13,602 
312,977 
86,009 
7
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Other creditors
1,340,989 
1,758,165 
8
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
100 Ordinary shares - B of £1 each
100 
100 
200 
200 
9
Average number of employees
During the year the average number of employees was 7 (2024: 17).
- 6 -